Bangue, Daisy Joy .
HRN: 11-49-08 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/03/2023
CEFOTAXIME 500MG (VIAL)
04/03/2023
04/09/2023
ORAL
500mg
BID
S/P NSVD With RMLE And Repair Thickly Meconium Stained
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes